MANAGEMENT AGREEMENT BY AND BETWEEN FIBRO-NTI, JOINT STOCK COMPANY AND FIBROBETON PRECAST CONCRETE LTD. DATED AS OF JUNE 24, 2001

MANAGEMENT AGREEMENT

BY AND BETWEEN

FIBRO-NTI, JOINT STOCK COMPANY

AND

FIBROBETON PRECAST CONCRETE LTD.

DATED AS OF JUNE 24, 2001

TABLE OF CONTENTS

ARTICLE 1		DEFINITIONS

	1.1.	Shareholders Joint Venture Agreement or Agreement	3
	1.2.	Ancillary Agreements	3
	1.3.	Parties	3
	1.4.	NTI	4
	1.5.	Taiyonic	4
	1.6.	NTI ASEAN	4
	1.7.	NTI and/or NTI ASEAN Affiliates	4
	1.8.	Corporation or Joint Venture	5
	1.9.	Corporation’s Business	5
	1.10.	Territory	5
	1.11.	Effective Date	5
	1.12.	NTI Intellectual Property Rights	5
	1.13.	Know-How	6
	1.14.	Materials	6
	1.15.	Process	6
	1.16.	Product	6
	1.17.	Masterbatch	6
	1.18.	Trademark	7
	1.19.	NTI and/or NTI ASEAN Trade Secrets	7
	1.20.	Other Agreed Upon Technologies	7
	1.21.	Net Sales	8
	1.22.	At Cost	8
	1.23.	Shareholder	8
	1.24.	Shares	8
	1.25.	Transfer of Shares	9
	1.26.	Transferor of Shares	9
	1.27.	Transfer Price for Shares	9
	1.28.	Transferee	9
	1.29.	Change of Control	9

ARTICLE 2		ENGAGEMENT OF FIBROBETON AS MANAGER

	2.1.	Engagement of Fibrobeton as Manager	10
	2.2.	Duties and Authority of Manager	10
	2.3.	Responsibility of Manager for Specific Activities	10

ARTICLE 3		PAYMENTS TO FIBROBETON FOR ITS SERVICES AS MANAGER OF THE CORPORATION

	3.1.	Basis for Payments	13
	3.2.	Compensation to Fibrobeton for Management Services Rendered to Fibro-NTI with Respect to Product	13
	3.3.	Compensation to Fibrobeton for Services Hereunder with Respect to Other Agreed Upon Technologies	13
	3.4.	When a Sale is Deemed to Occur	14
	3.5.	Support Year	14
	3.6.	Statements and Payment to the Parties Pursuant to the Ancillary Agreements	14
	3.7.	Books and Records	15

ARTICLE 4		PROTECTION OF FIBROBETON TRADE SECRETS

	4.1.	Identification of Fibrobeton Trade Secrets	17
	4.2.	Protection of Fibrobeton Trade Secrets	17
	4.3.	Protection of Fibrobeton Trade Secrets by Agents of ▇▇▇▇▇-▇▇▇	▇▇
	4.4.	Remedies in the Event of a Violation of Article 4 Hereof	18

ARTICLE 5		COVENANT TO OBSERVE THE DOCTRINE OF “CORPORATE OPPORTUNITY”

	5.1.	Doctrine of Corporate Opportunity and Observance Thereof	19
	5.2.	Agreement Not to Divert Resources	19
	5.3.	Remedies for Breach of Agreement Not to Divert Resources	20

ARTICLE 6		TERM OF AGREEMENT

	6.1.	Indefinite Term	21
	6.2.	Termination	21
	6.3.	Termination Upon Change of Control of a Party	22
	6.4.	Termination Upon Bankruptcy or Insolvency	22
	6.5.	Payment of Amounts Due	22
	6.6.	Cooperation Upon Termination	23
	6.7.	Non-Release of Obligations	23
	6.8.	Cessation of Rights Upon Termination	23

ARTICLE 7		DEFAULT

	7.1.	Event of Default	24
	7.2.	Remedies Upon Default or Breach	24
	7.3.	Non-Waiver of Rights	25

ARTICLE 8		DISPUTE RESOLUTION

	8.1.	Dispute Resolution by Arbitration	26
	8.2.	Disputes Not Subject to Arbitration	26
	8.3.	Conduct of Arbitration Proceedings	27
	8.4.	Designation of the “Prevailing Party”	27
	8.5.	Punitive Damages Excluded	27

ARTICLE 9		GENERAL PROVISIONS

	9.1.	Benefit of Parties	28
	9.2.	Counterparts	28
	9.3.	Cooperation	28
	9.4.	Index, Captions, Definitions and Defined Terms	29
	9.5.	Waiver of Compliance	29
	9.6.	Force Majeure	29
	9.7.	Notices	29
	9.8.	Entire Agreement	31
	9.9.	Validity of Provisions	31
	9.10.	Governmental Filings	32

iii

	9.11.	Payments.	32
	9.12.	Derivative Enforcement by NTI	32
	9.13.	Changes Subject to Approval of NTI.	32

APPROVAL OF NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION			34
APPROVAL OF ATAGENÇER, LLC			34

APPENDICES

APPENDIX I	NTI Affiliates
APPENDIX II	NTI ASEAN Affiliates
APPENDIX III	Trademark Documentation
APPENDIX IV	Form of Trade Secrecy Agreement for the Benefit of NTI and/or NTI ASEAN
APPENDIX V	Form of Trade Secrecy Agreement for the Benefit of Fibrobeton

MANAGEMENT AGREEMENT

This Management Representation Agreement (“Management Agreement”) is made and entered into as of June 24, 2001, by and between and FIBRO-NTI, JOINT STOCK COMPANY, a joint stock company organized under the laws of Turkey (“Fibro-NTI” or the “Corporation”) and FIBROBETON PRECAST CONCRETE LTD. (“Fibrobeton”). The address of Fibro-NTI, Joint Stock Company is Elemanari Sanaye Insaat, ve Tic. Ltd. Sti, Karanfil Cad. 27, 80620 1. Levent, Istanbul, Turkey, and the address of Fibrobeton Precast Concrete Ltd. is Elemanari Sanaye Insaat, ve Tic. Ltd. Sti, Karanfil Cad. 27, 80620 1. Levent, Istanbul, Turkey.

ARTICLE 1
DEFINITIONS

For the purposes of this Agreement, the following Definitions of terms shall apply:

1.1. Shareholders Joint Venture Agreement or Agreement.

That certain Shareholders Joint Venture Agreement by and between NTI (as hereinafter defined), and the other Parties (as hereinafter defined) dated as of June 24, 2001, for the formation and governance of a new entity under the laws of Turkey in the form of a limited liability company which shall be known as Fibro-NTI (“Fibro-NTI” or the “Corporation”).

1.2. Ancillary Agreements.

The following are the Ancillary Agreements and the Parties thereto:

	1.2.1.	Management Agreement between Fibrobeton and the Corporation (“Management Agreement”); and

	1.2.2.	Sales Representation Agreement between Atagençer, LLC (“Atagençer”) and the Corporation (“Sales Representation Agreement”); and

	1.2.3.	License Agreement between NTI and the Corporation (“License Agreement”); and

	1.2.4.	Technical Assistance and Marketing Support Agreement between NTI and the Corporation (“Technical Assistance Agreement”).

1.3. Parties.

The Parties to the Shareholders Joint Venture Agreement and/or the Ancillary Agreements, their successors and permitted assigns.

1.4. NTI.

Northern Technologies International Corporation, a company organized under the laws of the State of Delaware, U.S.A., the principal place of business of which is ▇▇▇▇ Lakes, Minnesota, U.S.A. NTI is the owner of the NTI Intellectual Property Rights (as hereinafter defined), and of a 50% interest in the Corporation pursuant to the Shareholders Joint Venture Agreement. In addition, NTI is the owner of a 50% interest in NTI ASEAN (as hereinafter defined).

1.5. Taiyonic.

Taiyonic Ltd., a company organized under the laws of Japan and an NTI Affiliate, which may help in marketing Product to Japanese companies for and on behalf of Fibro-NTI, either in the Territory or internationally as per terms to be agreed to with the support of NTI, as the Parties desire. Taiyonic is 50% owned by NTI and 50% by Taiyo Petroleum Gas Co. Ltd.

1.6. NTI ASEAN.

NTI ASEAN, LLC, a limited liability company, organized under the laws of the State of Nevada, U.S.A., whose registered office is in Reno, Nevada, U.S.A., to which NTI has assigned all of its right, title and interest in the NTI Intellectual Property Rights (as hereinafter defined) for the ASEAN Region (as set forth in Article 1.7.2 hereof), outside of Japan and the Republic of South Korea. NTI ASEAN is owned 50% by NTI and 50% by Taiyo Petroleum Gas Co. Ltd.

1.7. NTI and/or NTI ASEAN Affiliates.

All entities and/or individuals with which NTI and/or NTI ASEAN has a joint venture relationship, similar in character and style but not necessarily identical to the relationship created by the Shareholders Joint Venture Agreement and the Ancillary Agreements, or another form of alliance, for the development, manufacture, promotion, marketing, sales and applications engineering of Know-How, Materials, Process, Product and/or Masterbatch anywhere in the world.

1.7.1 NTI Affiliates.

Current NTI Affiliates are set forth in Appendix I hereof.

1.7.2 NTI ASEAN Affiliates.

Current NTI ASEAN Affiliates are set forth in Appendix II hereof.

1.8. Corporation or Joint Venture.

Fibro-NTI, that entity created in Turkey by the Parties pursuant to the Shareholders Joint Venture Agreement to conduct the Corporation’s Business in the Territory, also referred to herein as “Fibro-NTI”.

1.9. Corporation’s Business.

The Corporation’s Business shall be the manufacturing, marketing and distribution of Product, pursuant to NTI Intellectual Property Rights, and of any other technologies as shall be determined by the Parties in writing and made a part hereof pursuant to Article 1.21 of this Agreement, in the Territory.

1.10. Territory.

The Territory of Turkey and any other Territories as shall be agreed between the Parties.

1.11. Effective Date.

The date upon which all necessary formal approvals from the appropriate authorities of the Republic of Turkey for the Shareholders Joint Venture Agreement were obtained and the Corporation was duly registered pursuant to the Shareholders Joint Venture Agreement and the Ancillary Agreements as appropriate in the Territory.

1.12. NTI Intellectual Property Rights.

The Know-How, Materials, Process, Product, Masterbatch, Trademark, and NTI and/or NTI ASEAN Trade Secrets, (all as hereinafter defined), collectively, as such currently exist and shall hereafter be modified, developed and/or acquired by NTI.

1.13. Know-How.

The technology, formulae, methods and procedures developed by NTI at considerable expense over a period of many years, both directly and through NTI Affiliates; which are unique in nature and essential or useful in the proper application of the Process, together with all improvements and modifications with respect thereto.

1.14. Materials.

The constituent materials and chemicals of one or more formulations developed by NTI under strict quality control which are required for utilization of the Process.

1.15. Process.

The procedure utilizing the Know-How for the manufacture of polyethylene substances with corrosion inhibiting properties derived from the Materials as developed and specified by NTI, together with any improvements and modifications of the corrosion inhibiting technology as it relates directly to the manufacture of corrosion inhibiting polyethylene substances, together with future technology, knowledge and product development which is useful in the manufacture of the Product.

1.16. Product.

Volatile Corrosion Inhibiting (“VCI”) materials incorporated in polyethylene film and solid substances of polyethylene in the form of boxes, tubes and other containers, which may also include other volatile corrosion inhibiting host packaging substances such as paper, manufactured by means of the Process, incorporating the Materials and utilizing the Trademark, all of which have been developed and are owned by NTI.

1.17. Masterbatch.

Any formulation of the Materials which shall be designated by NTI, as appropriate, to be applied to the specific requirements for corrosion protection, as afforded by the Product, of a known customer desirous of protecting an identified object (or objects) which are to be subjected to an anticipated certain range of corrosive influences. In addition to Materials, Masterbatch shall generally also contain other substances for the purpose of facilitating the manufacture of Product utilizing the Process.

1.18. Trademark.

The name and style “ZERUST”, the “Zerust People”, “EXCOR”, the NTI Logo and the Color Yellow as applied to VCI packaging materials, including trade literature, technical specifications and application instructions, and promotional material pertaining thereto, together with any ancillary trademark registrations, which may differ between various jurisdictions. NTI is the registered owner of the Trademark in the Jurisdictions cited hereof in Appendix III.

1.19. NTI and/or NTI ASEAN Trade Secrets.

All information deemed and designated confidential, both in the Shareholders Joint Venture Agreement and in the Ancillary Agreements and hereafter, including but not limited to information regarding the Know-How, Materials, Process, Product, and/or Masterbatch, together with information regarding technology, customers, research, techniques, processes, applications, formulae, cost data, customer lists, suppliers, competition, marketing strategy, supply relationships, costs and cost accounting, memoranda, diagrams, pictures, computer software and programs and records contained therein, sales information, financial information, costs, pricing data and profits, relating to the business and Intellectual Property Rights of NTI, NTI ASEAN, the Corporation and NTI and/or NTI ASEAN Affiliates, both in the Territory and elsewhere.

1.20. Other Agreed Upon Technologies.

In conformity with the objectives of the Parties hereto to expand the commercial activities of Fibro-NTI over time, the Parties shall endeavor to identify products, materials and/or technologies, which are both compatible with the Corporation’s Business, and susceptible of being profitably marketed through and/or by the Corporation in the Territory. Upon joint agreement of the Parties, in writing, to adopt such new products, materials and/or technologies within the scope of the Corporation’s activities, and successful negotiation of requisite commercial rights to commercialize such new products, materials and/or technologies in the Territory, such new products, materials and/or technologies shall be deemed to be incorporated within the Corporation’s activities as “Other Agreed Upon Technologies” to be treated as set forth in the Shareholders Joint Venture Agreement and the Ancillary Agreements.

1.21. Net Sales.

The total proceeds from the sale of Product and Other Agreed Upon Technologies sold by the Corporation in normal, bona fide commercial transactions on an arm’s length basis to, by, with, or through an entity which is not affiliated with any Party of this Agreement, less the following items: (i) sales discounts (including sales rebates); (ii) sales returns; (iii) shipping and transaction costs, such as Value Added Tax, CIF charges and packaging expenses; and (iv) sales commissions to third parties.

1.22. At Cost.

Without profit component of any kind, direct or indirect, to the particular Party in the given case (although nothing herein shall preclude such Party from recovering all costs - direct and indirect - arising out of any transaction with the proscription “At Cost”).

1.23. Shareholder.

Any holder, from time to time, of Shares of the Corporation and who presently is a Party to the Shareholders Joint Venture Agreement or who may become a Party to the Shareholders Joint Venture Agreement in the future.

1.24. Shares.

Any validly issued shares of the Corporation owned by any Shareholder pursuant to the Shareholders Joint Venture Agreement.

1.25. Transfer of Shares.

Any sale, transfer, assignment, pledge or disposition of Shares of the Corporation in any way, whether voluntarily or involuntarily, by gift, legal procedure, operation of law, or any other means.

1.26. Transferor of Shares.

A Shareholder who declares an intention to Transfer Shares of the Corporation and/or initiates the Transfer of Shares.

1.27. Transfer Price for Shares.

The price per share for the Shares of the Corporation offered on an arm’s-length basis by an outside party to the Transferor in a bona fide written offer.

1.28. Transferee.

Any new Shareholder, who has heretofore not been a party to the Shareholders Joint Venture Agreement, who acquires his Shares pursuant to the provisions of the Shareholders Joint Venture Agreement, and who thereafter signs and becomes a Party to the Shareholders Joint Venture Agreement.

1.29. Change of Control.

Any change in ownership, management, control or scope of business activities of a Party which could affect the performance of the duties and/or obligations of such Party under the Shareholders Joint Venture Agreement or the Ancillary Agreements.

ARTICLE 2
ENGAGEMENT OF FIBROBETON AS MANAGER

2.1. Engagement of Fibrobeton as Manager.

Fibro-NTI hereby engages Fibrobeton to implement the Purposes of the Joint Venture (as defined in Article 3 of the Shareholders Joint Venture Agreement) and to manage, supervise and conduct the Corporation’s Business. Fibrobeton hereby accepts such engagement and agrees to serve in such capacity in accordance with the terms hereof and with the terms of the Shareholders Joint Venture Agreement and the other Ancillary Agreements.

2.2. Duties and Authority of Manager.

Fibrobeton shall have all authority which may be necessary, desirable or appropriate in connection with the discharge of Fibrobeton’s duties hereunder, subject only to applicable limitations contained in the Shareholders Joint Venture Agreement and the Ancillary Agreements, and the provisions of Article 2 hereof. Fibrobeton shall use its best efforts in the performance of its duties and shall discharge same and conduct the Corporation’s Business in a good, workmanlike and commercially reasonable manner and in accordance with sound business practices and the standard of diligence and care normally exercised by duly qualified persons in the performance of comparable work in the Territory.

2.3. Responsibility of Manager for Specific Activities.

In the course of fulfilling its responsibilities pursuant to this Management Agreement, Fibrobeton shall carry out the following activities on behalf of Fibro-NTI.

	2.3.1.	Cause Fibro-NTI to comply with the terms of the Shareholders Joint Venture Agreement and the Ancillary Agreements;

	2.3.2.	Acquire such materials, supplies, equipment, services and technical assistance as may be necessary, desirable or appropriate for the conduct of the Corporation’s Business;

	2.3.3.	Procure from outside experts, consultants and professionals such engineering, legal, advertising, promotional, and, except for accounting services (which shall be provided in accordance with the Shareholders Joint Venture Agreement), other advisory and professional services as may be necessary, desirable or appropriate for the conduct of the Corporation’s Business;

	2.3.4.	Protect, keep and maintain the properties and assets of Fibro-NTI and such properties and assets of the Parties to the Shareholders Joint Venture Agreement as are in the Corporation’s actual possession;

	2.3.5.	Hire, train and supervise such personnel as may be necessary, desirable or appropriate for the conduct of the Corporation’s Business;

	2.3.6.	Provide all executive and administrative responsibilities and services necessary, desirable or appropriate for the conduct of the Corporation’s Business;

	2.3.7.	Cause Fibro-NTI to comply with all laws applicable to it;

	2.3.8.	Process all customer orders, provide ▇▇▇▇▇▇▇▇ to customers and make adjustments with customers as appropriate;

	2.3.9.	Manage the credit risk of the Corporation including making inquiries regarding the creditworthiness of potential customers;

	2.3.10.	Manufacture or cause the manufacture of Product and Other Agreed Upon Technologies in the Territory, and, as far as Fibrobeton and its affiliates are concerned, At Cost;

	2.3.11.	Maintain the books and records of the Corporation in accordance with the normal practices of similar businesses in the Territory;

	2.3.12.	Prepare and file with governmental authorities all required reports and returns relating to the Corporation’s Business;

	2.3.13.	Procure on behalf of the Corporation such product liability, public liability and other liability, casualty, and general insurance, as may be necessary, desirable and appropriate for the conduct of the Corporation’s Business in the Territory;

	2.3.14.	Establish and maintain a segregated bank account or accounts in the name of the Corporation for the deposit and disposition of all funds generated by and disbursed for the Corporation’s Business;

	2.3.15.	Apply standards for the extension of credit and establish and maintain systems for the collection of all accounts, including overdue accounts in accordance with the normal practices of similar businesses in the Territory;

	2.3.16.	Coordinate the pricing and discount structure for the sale of Product and Other Agreed Upon Technologies to customers and/or distributors in the Territory, which will result in a reasonable profit to the Corporation, subject to the provisions of Article 7.3.17. of the Shareholders Joint Venture Agreement;

	2.3.17.	Arrange for the preparation and delivery of the Corporation’s financial statements as required by the Shareholders Joint Venture Agreement;
	2.3.18.	Cause Agents of the Corporation to execute appropriate Trade Secrecy Agreements for the benefit of NTI and/or NTI ASEAN, substantially in the form of Appendix IV hereto; and to execute Trade Secrecy Agreements for the benefit of Fibrobeton, substantially in the form of Appendix V hereto; and
	2.3.19.	Perform or cause the Corporation to perform all other acts and functions as may be necessary, desirable or appropriate in connection with the conduct of the Corporation’s Business within its corporate authority as stated in Fibro-NTI’s Articles of Association, subject to the Shareholders Joint Venture Agreement, the Ancillary Agreements and duly adopted Resolutions of the Board of Directors.

ARTICLE 3
PAYMENTS TO FIBROBETON FOR ITS SERVICES AS
MANAGER OF THE CORPORATION

3.1. Basis for Payments.

Fibro-NTI shall make payments to Fibrobeton which are provided for in Article 3 of this Management Agreement in consideration of the services performed by Fibrobeton as set forth in Articles 2 and 3 hereof. Such payments shall be made throughout the full term of this Management Agreement as compensation for the services set forth above and duly provided by Fibrobeton.

3.2. Compensation to Fibrobeton for Management Services Rendered to Fibro-NTI with Respect to Product.

As compensation for the management services to be rendered by Fibrobeton pursuant to this Management Agreement with respect to Product, Fibro-NTI shall pay to Fibrobeton a fee equal to seven and a half percent (7.5%) of the amount of Net Sales of Product, plus reimbursement of reasonable, direct out-of-pocket expenses (At Cost) paid or incurred by Fibrobeton in the discharge of its responsibilities hereunder. Such amounts shall be paid to Fibrobeton within thirty (30) days after the conclusion of each quarterly period, based upon Net Sales and out-of-pocket expenses during the preceding quarterly period. There shall, however, be no separate or additional compensation in conjunction with services, such as accounting, invoicing or other management or administrative functions, which services are to be performed by Fibrobeton within the scope of its responsibilities as Manager.

3.3. Compensation to Fibrobeton for Services Hereunder with Respect to Other Agreed Upon Technologies.

Compensation to Fibrobeton for services rendered within the scope of this Management Agreement with respect to Other Agreed Upon Technologies shall be as agreed between the Parties on a case-by-case basis. Unless otherwise agreed between the Parties, however, Fibrobeton shall perform substantially the same functions, and have substantially the same rights, duties and obligations with respect to Other Agreed Upon Technologies as it does with respect to Product. Accordingly, Fibrobeton’s total Compensation with respect to the services rendered with respect to Other Agreed Upon Technologies shall, unless otherwise agreed between the Parties, be equal to the total Compensation paid to Fibrobeton for the services it renders to the Corporation with respect to Product.

3.4. When a Sale is Deemed to Occur.

A sale shall be deemed to have occurred when Product or goods based upon Other Agreed Upon Technologies have been billed or (if not billed) delivered to and fully paid for by a customer.

3.5. Support Year.

The term Support Year (“Support Year”) shall mean any twelve (12) month period ending on December 31, except that the first Support Year shall commence on the Effective Date and end on the next December 31 date.

3.6. Statements and Payment to the Parties Pursuant to the Ancillary Agreements.

Within sixty (60) days after the last day of each quarterly period in each Support Year, Fibrobeton shall cause the Corporation:

3.6.1.	To prepare and deliver to the Parties a complete and accurate statement setting forth for the quarter just ended and separately and cumulatively for, and with respect to all elapsed quarterly periods for the Support Year:
	(i)	The total amount of Net Sales of Product (broken down in reasonable detail by individual volumes and customers and showing all costs and discounts leading to the establishment of the Net Sales figure for each customer); and

	(ii)	The total amount of compensation based upon Net Sales of Product (computed as hereinbefore provided) payable to Fibrobeton for its Management Services to the Corporation hereunder; and

	(iii)	The total amount of compensation based upon Net Sales of Product payable to Atagençer pursuant to the Sales Representation Agreement; and

	(iv)	The total amount of compensation based upon Net Sales of Product payable to NTI pursuant to the License Agreement; and

	(v)	The total amount of compensation based upon Net Sales of Product payable to NTI pursuant to the Technical Assistance and Marketing Support; and
	(vi)	The total amount of Net Sales of Other Agreed Upon Technologies (broken down in reasonable detail by volumes and individual customers and showing all costs and discounts leading to the establishment of the Net Sales figure for each customer); and
	(vii)	The total amount of compensation based upon Net Sales of Other Agreed Upon Technologies (computed as hereinbefore provided) payable to Fibrobeton for its Management Services to the Corporation hereunder; and
	(viii)	The total amount of compensation based upon Net Sales of Other Agreed Upon Technologies (computed as hereinbefore provided) payable to Atagençer pursuant to the Sales Representation Agreement; and
	(ix)	The total amount of compensation based upon Net Sales of Other Agreed Upon Technologies (computed as hereinbefore provided) payable to NTI pursuant to the License Agreement; and

	(x)	The total amount of compensation based upon Net Sales of Other Agreed Upon Technologies (computed as hereinbefore provided) payable to NTI pursuant to the Sales Representation Agreement.

3.6.2.	Pay the full amount of compensation to the Parties which each Party is entitled pursuant Article 3.6.1. hereof.

3.7. Books and Records.

Fibrobeton covenants and agrees that, as part of its duties under Article 2 hereof, it will cause Fibro-NTI:

	3.7.1.	To keep complete and accurate commercial and financial records and books of account showing the amount of ▇▇▇▇▇▇▇▇ to customers and the amount of deductions therefrom in arriving at Net Sales of Product and of Other Agreed Upon Technologies and all additional data and information which may be reasonably necessary to enable Fibrobeton or its independent accountants to verify the completeness and accuracy for each item of information which Fibro-NTI is required to set forth in each of the statements referred to in Article 3.6.1.;

	3.7.2.	To keep all such commercial and financial records and books of account at its principal office and to preserve all such records and books of account for a period of not less than three (3) years from and after the date on which such records, or the last entry in such books of account was made, whichever shall be later; and

	3.7.3.	To make such commercial and financial records, books of account, data and information available to Fibrobeton and/or its representatives and independent accountants and to give such representatives or accountants free and complete access, at any reasonable time or times, to all such records, books of account, data and information, for the purposes of examining the same and verifying the completeness and accuracy of each item of information which Fibro-NTI is required to set forth in each of the statements referred to in Article 3.7.1. hereof. In addition, the Parties shall have the right to make copies of any of the foregoing. The independent accountants of Fibro-NTI shall in the ordinary course of business provide written confirmation and certification to the Parties, at least annually, to the Financial Bank Records of Fibro-NTI. The cost of such reports shall be borne by Fibro-NTI. In the event that a Party shall cause its representatives to confirm or verify the accuracy of the data supplied by the Corporation, then the costs and fees of such representatives shall be borne by such Party, unless such representatives shall determine, to the satisfaction of the Corporation’s independent accountants, that there is a variation in the reporting of the Financial Bank Records or more, in which event the costs and fees of such Party’s representatives and/or accountants shall be borne by the Corporation.

ARTICLE 4
PROTECTION OF FIBROBETON TRADE SECRETS

4.1. Identification of Fibrobeton Trade Secrets.

The Parties acknowledge that it is not intended that Fibrobeton impart its technology or trade secrets to the Corporation or, through the Corporation, to NTI. The Parties recognize, however, that Fibrobeton may impart information to the Corporation to further the Corporation’s Business, which Fibrobeton considers to be proprietary in nature and thus wishes to be kept confidential, and that such Fibrobeton Trade Secrets may come to be imparted to NTI through the Corporation. In order for such information to be considered under the category of Fibrobeton Trade Secrets, Fibrobeton must alert the Corporation and NTI to the fact that it intends to impart information it considers proprietary to the Corporation, in writing, in advance of imparting such information, and clearly identify such information as a Fibrobeton Trade Secret (“Fibrobeton Trade Secrets”).

4.2. Protection of Fibrobeton Trade Secrets.

Fibro-NTI agrees that during the term of this Management Agreement, as well as following its termination and for all times thereafter, it shall keep secret and confidential all Fibrobeton Trade Secrets which it now knows or may hereafter come to know as a result of the Shareholders Joint Venture Agreement and the Ancillary Agreements. Fibrobeton Trade Secrets shall not be disclosed by Fibro-NTI to third parties and shall be kept secret and confidential, except (i) to the extent that the same have entered into the public domain by means other than the improper actions of Fibro-NTI, or (ii) to the extent that the disclosure thereof may be required pursuant to the order of any court or other governmental body. If a Fibrobeton Trade Secret shall be in the public domain as the result of an act by Fibro-NTI or any Agent thereof, then Fibro-NTI shall nevertheless continue to keep such Fibrobeton Trade Secret secret and inviolate.

4.3. Protection of Fibrobeton Trade Secrets by Agents of Fibro-NTI.

Neither Fibro-NTI, nor its Agents (as hereinafter defined), shall at any time copy, remove from their proper location - be it within the Corporation or elsewhere - or retain without Fibrobeton’s prior written consent, the originals or copies of any Fibrobeton Trade Secrets. It is understood that from time to time it may be necessary that certain of the foregoing items be copied or removed from their location; however, this shall be done subject to the requirement of this Article that the original material be returned to its proper location as soon as possible and that the confidential nature and integrity of the foregoing as Fibrobeton Trade Secrets be strictly maintained both as to original documents and copies thereof.

	4.3.1.	Insofar as the officers, employees and consultants of Fibro-NTI (herein collectively “Agents”) who come in contact with Fibrobeton Trade Secrets are concerned, Fibro-NTI shall cause such Agents to enter into Fibrobeton Trade Secrecy Agreements substantially in the form of Appendix V to this Agreement. Fibro-NTI shall exert its best efforts to cause its Agents to adhere to and to abide by the provisions, restrictions and limitations of the Fibrobeton Trade Secrecy Agreements which efforts shall include the institution and prosecution of appropriate litigation if such be necessary and desirable.

	4.3.2.	The Parties hereby agree and acknowledge that Fibrobeton is an intended third party beneficiary of the Fibrobeton Trade Secrecy Agreements, and that Fibrobeton may in its sole discretion, on its own behalf or derivatively and/or on behalf of the Corporation directly enforce the provisions of the Fibrobeton Trade Secrecy Agreements and/or any breach thereof against any and all Agents of Fibro-NTI (as defined in Article 4.3.1 hereof) who have executed same.

4.4. Remedies in the Event of a Violation of Article 4 Hereof.

It is understood and recognized by Fibro-NTI that in the event of any violation by Fibro-NTI and/or its Agents of the provisions of Article 4 hereof, Fibrobeton’s remedy at law will be inadequate and Fibrobeton will suffer irreparable injury. Accordingly, Fibro-NTI consents to injunctive and other appropriate equitable relief upon the institution of legal proceedings therefor by Fibrobeton and in any court of competent jurisdiction to protect Fibrobeton Trade Secrets. Such relief shall be in addition to any other relief to which Fibrobeton may be entitled at law or in equity, which shall include but not be limited to the right of immediate termination of this Management Agreement.

ARTICLE 5
COVENANT TO OBSERVE THE
DOCTRINE OF “CORPORATE OPPORTUNITY”

5.1. Doctrine of Corporate Opportunity and Observance Thereof.

It is the intent of the Parties to this Management Agreement, the Shareholders Joint Venture Agreement and to the other Ancillary Agreements to deal solely with each other with respect to the commercial, technical and strategic development and implementation of the Corporation’s Business in the Territory. Consequently, the Parties to each agreement cited above hereby renounce and covenant not to engage in any activity which would either (a) negatively impact the performance of their duties under the Shareholders Joint Venture Agreement or the Ancillary Agreements in the Territory, or (b) have the effect of displacing or substituting Net Sales of Product and/or of Other Agreed Upon Technologies, and/or the application of NTI Intellectual Property Rights, in the Territory; except as specifically agreed to by the Parties in furtherance of the Corporation’s Business (“Corporate Opportunity”).

5.2. Agreement Not to Divert Resources.

Fibrobeton and Fibro-NTI agree that during the term of this Management Agreement they shall not, directly or indirectly, in any capacity whatsoever, engage in, own, manage, operate, control, act as a consultant to, have a financial interest in, or otherwise participate in the ownership, licensing, management, operation or control of, a business which would impede, substitute, displace or divert Net Sales of Product and/or of Other Agreed Upon Technologies from the Corporation within the Territory except through the Corporation in furtherance of the Corporation’s Business. During said term Fibrobeton shall not in any way, directly or indirectly, divert, take away or interfere with or attempt to divert, take away or interfere with, any of the customers, accounts, suppliers, employees, representatives or patronage of the Corporation. In the event that this Management Agreement is terminated: (i) because of a material Breach of the Shareholders Joint Venture Agreement by a Party; (ii) because of a material Breach of any Ancillary Agreement by a Party; (iii) upon the bankruptcy or other adverse condition of a Party as described in Article 6 hereof; (iv) pursuant to Article 7 hereof; or (v) upon a Breach of Article 4 or 5 hereof, then the Party in Breach or subject to such adverse condition shall continue to be bound by the provisions of Article 4 of this Management Agreement for a period of three years following the date of termination, but Fibro-NTI shall at no time be permitted to use Fibrobeton Trade Secrets, for any activity outside the Corporation, including but not limited to such activities which would have the effect of diverting resources from the Corporation.

5.3. Remedies for Breach of Agreement Not to Divert Resources.

It is understood and recognized by the Parties that in the event of a violation of the provisions of Article 5 hereof by a Party, the remedy at law will be inadequate and that the other Party to this Management Agreement shall suffer irreparable injury. Accordingly, each Party to this Management Agreement consents to injunctive or other appropriate equitable relief upon the institution of legal proceedings therefor by the non-violating Party. Such relief shall be in addition to any other relief to which a Party may be entitled at law or in equity, which shall include, but not be limited to, the right of immediate termination of this Management Agreement.

ARTICLE 6
TERM OF AGREEMENT

6.1. Indefinite Term.

This Management Agreement shall become effective on the Effective Date and shall, unless otherwise terminated in accordance with the provisions hereof, continue in effect for an indefinite term of years.

6.2. Termination.

This Management Agreement, having become effective as of the Effective Date hereof, shall continue in effect unless:

	6.2.1.	Terminated by either Party in accordance with the provisions of Articles 4 and/or 5 hereof;

	6.2.2.	Terminated in accordance with Article 6.3 and/or Article 6.4 hereof;

	6.2.3.	Terminated by either Party by reason of a material Breach or Default of this Management Agreement by the other Party which has not been cured or remedied in accordance with Article 7 hereof; or

	6.2.4.	Terminated automatically, in conjunction with the termination of the Shareholders Joint Venture Agreement or any of the other Ancillary Agreements by a Party thereto by reason of a material Breach (as therein defined) or Default (as therein defined) of any such Agreement by a Party thereto, which Breach or Default has not been cured or remedied in accordance with the curative provisions thereof. In such event, this Management Agreement shall likewise terminate on the same date, without any further act or notice given by a Party hereto.

6.3. Termination Upon Change of Control of a Party.

In the event that a Change of Control of a Party hereto shall occur, then the other Party may, upon six (6) months prior written notice given to such Party, terminate this Management Agreement, unless the Change of Control of such Party shall have been effected upon prior notification and with the written understanding of the other Party.

6.4. Termination Upon Bankruptcy or Insolvency.

If Fibro-NTI hereto shall become bankrupt or insolvent or shall file for any debtor relief proceedings, or if there shall be filed in Court against a Party legal proceedings for bankruptcy, insolvency, reorganization or for the appointment of a receiver or trustee of all or a portion of such Party’s property, or if a Party makes an assignment for the benefit of creditors or petitions for or enters into an arrangement for debtor relief and such proceedings as are described aforesaid are not dismissed within a period of ninety (90) days after the institution thereof, then, at the option of the other Party, this Management Agreement shall forthwith terminate by written notice given to the Party who has filed, instituted or against whom any of the proceedings aforesaid have been brought; provided that if a stay has been granted by a Trustee or Judge in Bankruptcy by virtue of which this Management Agreement is to be deemed an executory contract, then the other Party shall continue to perform under the terms of this Management Agreement if:

	6.4.1.	Payments due under this Management Agreement for past obligations are rendered in full by the Party subject to such proceedings;

	6.4.2.	Payments due under this Management Agreement for present obligations are rendered by the Party subject to such proceedings pursuant to a payment schedule acceptable to the other Party; and

	6.4.3.	All other provisions of this Management Agreement are complied with fully by the Party subject to such proceedings.

6.5. Payment of Amounts Due.

In the event of termination of this Management Agreement, each Party shall pay to the other Party all amounts due and owing pursuant to this Management Agreement prior to the effective date of termination.

6.6. Cooperation Upon Termination.

Upon termination of this Management Agreement, the Corporation shall cooperate with Fibrobeton in transferring Fibrobeton Trade Secrets, if any, to Fibrobeton or its designated assignee; and Fibrobeton and Corporation shall cooperate with NTI and/or NTI ASEAN in transferring NTI Intellectual Property Rights, together with NTI and/or NTI ASEAN Trade Secrets to NTI, NTI ASEAN or their designated assignee.

6.7. Non-Release of Obligations.

The termination of this Management Agreement shall not release the Parties from their obligations to settle all financial accounts between themselves in cash forthwith. Notwithstanding the termination hereof, each Party shall be responsible for the performance of all of its obligations and responsibilities hereunder up to the effective date of termination. As provided in Article 4, upon termination of this Management Agreement, Fibrobeton Trade Secrets shall continue to be kept secret and confidential.

6.8. Cessation of Rights Upon Termination.

Upon the termination of this Management Agreement, for reason of Default or Breach of this Management Agreement or of the Shareholders Joint Venture Agreement or an Ancillary Agreement, all rights which the Party in Default (“Defaulting Party”) may have under or pursuant to this Management Agreement shall forthwith cease and terminate. If a dispute as to whether a Default or Breach exists is submitted to Arbitration under Article 8 hereof, the Parties shall jointly appoint a trustee or agent to oversee the execution of the duties hereunder and the protection of rights hereunder of the Party allegedly in Default and/or Breach. If the Parties cannot agree on a trustee or agent for such purposes, the Arbitration Panel shall forthwith appoint same.

ARTICLE 7
DEFAULT

7.1. Event of Default.

A Default (“Default”) hereunder shall exist in the event of:

	7.1.1.	Non-payment of funds by one Party to another Party when due and owing; and/or

	7.1.2.	A material Breach (“Breach”) of any provision of this Management Agreement other than Articles 4 and/or 5 hereof, of the Shareholders Joint Venture Agreement, or any of the other Ancillary Agreements; and/or

	7.1.3.	A Breach of Articles 4 and/or 5 hereof.

7.2. Remedies Upon Default or Breach.

The remedies available to each Party in an instance of Default or Breach by the other Party shall be as follows:

7.2.1.

If a Party shall fail to make any payments required hereunder after the same are due, (other than due to governmental delays) or if it shall commit a Default or Breach in the performance of, or by failure to observe and comply with, any other material term or provision of this Management Agreement to be performed, observed or complied with by it, then the Party against whom such Default or Breach shall have been committed shall have the right to declare a Default and terminate this Management Agreement unless the Party in Default or Breach shall cure such failure to pay, or cause the same to be cured, within thirty (30) days (fifteen (15) days in case of monetary default) after receipt of written notice from the other Party, provided, however, that if the Party in Default or Breach commences to cure same within the curative period specified herein, then the right of termination shall be held in abeyance for a reasonable period of time so long as the Party in Default or Breach proceeds to cure such Default or Breach with due diligence. A Party’s right of termination shall be in addition to and not in limitation of any of his other rights at law or in equity based upon the other Party’s Default or Breach. Any notice of termination shall stipulate the effective date of termination which shall be not less than three (3) months nor more than six (6) months following the date that such notice is given.

7.2.2.

Notwithstanding the foregoing, in the event of a violation of Articles 4 and/or 5 hereof by a Party hereto, the other Party may at its sole discretion terminate this Management Agreement with immediate effect upon giving notice to the Party in Default or Breach of Articles 4 and/or 5 hereof as provided herein.

7.3. Non-Waiver of Rights.

A Party’s failure to terminate this Management Agreement on account of any Breach or Default by the other Party as provided in Article 7.1 or 7.2 hereof shall in no event constitute or be deemed to constitute a waiver by such Party of its right to terminate this Management Agreement at any time while any such Breach or Default continues (subject to the provisions of Article 7.2 hereof), or on account of any subsequent Breach or Default by a Party.

ARTICLE 8
DISPUTE RESOLUTION

8.1. Dispute Resolution by Arbitration.

Any and all disputes, except as excluded under Article 8.2 hereof, which may arise between the Parties during the term of this Management Agreement, after the termination thereof, or following the liquidation or dissolution of the Corporation, upon failure by the Parties to amicably resolve same after mutual good faith negotiations, shall be exclusively settled by arbitration, including but not limited to, the following:

	8.1.1.	A dispute as to whether a Default exists;

	8.1.2.	A dispute as to whether a Default entitles the non-defaulting Party to terminate this Management Agreement;

	8.1.3.	A dispute as to the validity of this Article 8;

	8.1.4.	A dispute relating to the construction, meaning, interpretation, application or effect of this Management Agreement or anything contained herein;

	8.1.5.	A dispute as to the rights, obligations or liabilities of the Parties hereunder.

8.2. Disputes Not Subject to Arbitration.

Notwithstanding anything to the contrary set forth in this Management Agreement:

	8.2.1.	Arbitration may not be invoked regarding matters expressed in this Management Agreement to be agreed upon by or determined with the consent or approval of both Parties.


	8.2.2.	Arbitration may not be invoked if Fibrobeton, in its capacity as Manager of Fibro-NTI, causes Fibro-NTI to commit a Breach or Default of this Management Agreement or of the Shareholders Joint Venture Agreement or of any of the Ancillary Agreements. Such action shall be considered a Breach by Fibrobeton of Article 6.2 hereof.

8.2.3.

Arbitration may not be invoked if a Party violates the provisions of this Management Agreement relating to Fibrobeton Trade Secrets or Corporate Opportunity. In such event, the remedies set forth in Articles 4, 5 and/or 7 hereof shall apply.

8.3. Conduct of Arbitration Proceedings.

Such arbitration proceedings shall be conducted in English and shall be carried on in the City of Brussels or any other place mutually agreeable to the Parties, under the UNCITRAL Arbitration Rules. In the interpretation of this Management Agreement, the laws of Turkey shall apply. Judgment upon the award rendered by the arbitrator in favor of the Prevailing Party, which shall include an award concerning the payment of costs, attorneys’ fees, and expenses of the arbitration proceedings, may be entered in any court of competent jurisdiction and assets may be attached in any Turkey in the world pursuant to such judgment.

8.4. Designation of the “Prevailing Party”.

In each case in which arbitration is invoked under this Management Agreement, the Shareholders Joint Venture Agreement or any of the other Ancillary Agreements, the arbitration panel shall be required to designate one or the other Party as the Prevailing Party (“Prevailing Party”).

8.5. Punitive Damages Excluded.

The Prevailing Party in an arbitration proceeding convened hereunder shall be awarded in arbitration all reasonable damages plus documented costs incurred in pursuing its arbitration claim, including but not limited to legal fees and travel expenses, but shall not be entitled to exemplary or punitive damages.

ARTICLE 9
GENERAL PROVISIONS

9.1. Benefit of Parties.

All of the terms and provisions of this Management Agreement, the Shareholders Joint Venture Agreement and of the other Ancillary Agreements shall be binding upon the Parties executing same and their respective permitted successors and assigns. Except as expressly provided herein, a Party may not assign its rights and obligations to a third party without the written consent of the other Party; provided, however, that a Party may assign this Management Agreement and all of such Party’s rights hereunder (or a portion of this Management Agreement and the rights hereunder relating thereto) to, or provide for the performance of all or part of such Party’s obligations hereunder by, an entity which controls, is controlled by or is under common control with such Party. In such event, (i) the assignor shall unconditionally guarantee the performance and obligations of the assignee and shall not be released of its liabilities, obligations and responsibilities hereunder and (ii) the assignee shall expressly assume in writing and agree to perform such obligations, liabilities and responsibilities of the assignor.

9.2. Counterparts.

This Management Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

9.3. Cooperation.

During the term of this Management Agreement, each Party shall cooperate with and assist the other Party in taking such acts as may be appropriate to enable all Parties to effect compliance with the terms of this Management Agreement as well as those of the Shareholders Joint Venture Agreement and the other Ancillary Agreements and to carry out the true intent and purposes thereof.

9.4. Index, Captions, Definitions and Defined Terms.

The captions of the Articles of this Management Agreement and subsections thereof are solely for convenient reference and shall not be deemed to affect the meaning or interpretation of any provisions hereof. Notwithstanding the foregoing, the Definitions set forth in Article 1 hereof, together with any other defined terms in this Management Agreement, as identified by their insertion in parentheses and quotation marks (“Defined Terms”), shall be incorporated herein as written, made a part hereof, and govern the interpretation of the text of this Management Agreement, irrespective of whether such Definitions or Defined Terms appear in the text of this Management Agreement before or after they are defined.

9.5. Waiver of Compliance.

The Party for whose benefit a warranty, representation, covenant or condition is intended may in writing waive any inaccuracies in the warranties and representations contained in this Management Agreement or waive compliance with any of the covenants or conditions contained herein and so waive performance of any of the obligations of the other Party hereto, and any Breach or Defaults hereunder; provided, however, that such waiver shall not affect or impair the waiving Party’s rights in respect to any other covenants, condition, Breach or Default hereunder.

9.6. Force Majeure.

In the event that a Party is prevented or delayed from performing, fulfilling or completing an obligation provided for in this Management Agreement as a result of delays caused by strikes, lock-outs, unavailability of materials, acts of God, acts of any national, state or local governmental agency or authority of a foreign government, war, insurrection, rebellion, riot, civil disorder, fire, explosion or the elements, then the time for performance, fulfillment or completion shall be extended for a period not exceeding the number of days by which the same was so delayed. If a force majeure event shall be in existence for one year or more, then either Party shall have the right to terminate this Management Agreement at any time thereafter by giving at least thirty (30) days written notice of termination to the other Party, provided that the force majeure event continues to be in effect as of the date that such notice is given.

9.7. Notices.

All notices, requests, demands or other communications which are required or may be given pursuant to the terms of this Management Agreement shall be in writing and delivery shall be effective in all respects if delivered (i) by telefax promptly confirmed by letter, (ii) personally, (iii) by registered or certified air mail, postage prepaid, or (iv) by neutral commercial courier service, such as Federal Express, DHL, UPS or equivalent, as follows:

If to Fibrobeton, to:	Fibrobeton Precast Concrete Ltd.
	Elemanari Sanaye Insaat

	ve Tic. Ltd. Sti, Karanfil Cad. 27

	80620 1. Levent

	Istanbul, Turkey

If to Fibro-NTI, to:	Fibro-NTI
	Elemanari Sanaye Insaat

	ve Tic. Ltd. Sti, Karanfil Cad. 27

	80620 1. Levent

	Istanbul
	Turkey

Copy to:	Northern Technologies International Corporation
	Attention: President
	▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇
	▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
	Telefax: ▇-▇▇▇-▇▇▇-▇▇▇▇

Copy to:	Northern Technologies International Corporation
	Attention: Chairman
	▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇
	▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
	Telefax: ▇-▇▇▇-▇▇▇-▇▇▇▇

Copy to:	Atagençer, LLC
	Attention: ▇▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇
	▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇
	▇▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
	Tel: ▇▇▇-▇▇▇-▇▇▇▇
	Fax: ▇▇▇-▇▇▇-▇▇▇▇

or to such other address as may be specified in writing by any of the above.

9.8. Entire Agreement.

This Management Agreement, together with the Shareholders Joint Venture Agreement and the other Ancillary Agreements, contain the entire understanding of the Parties as of the date of each such agreement. There are no representations, promises, warranties, covenants, agreements or undertakings other than those expressly set forth or provided for in this Management Agreement, the Shareholders Joint Venture Agreement and the other Ancillary Agreements, and the same supersede all prior agreements and understandings between the Parties with respect to the relationships and transactions contemplated by this Management Agreement. It is the intent of the Parties to develop the relationship established hereunder, however, and to amend and supplement this Management Agreement so as to provide for expansion both of Net Sales of Product and of the scope of the Corporation’s Business with Other Agreed Upon Technologies. Any amendment or supplement to this Management Agreement, the Shareholders Joint Venture Agreement and the other Ancillary Agreements must, however, be clearly identified as such and set forth in writing (“Supplemental Documents”). Supplemental Documents may include Corporate Resolutions and/or other written exchanges between Parties, but must be manually signed, in the original, by duly authorized representatives of the Parties to constitute valid Supplemental Documents for purposes hereof.

9.9. Validity of Provisions.

Should any part of this Management Agreement, the Shareholders Joint Venture Agreement or the other Ancillary Agreements be declared by any court of competent jurisdiction to be invalid, such decision shall not affect the validity of the remaining portion, which remaining portion shall continue in full force and effect as if such instrument had been executed with the invalid portion thereof eliminated therefrom, it being the intent of the Parties that they would have executed the remaining portion without including any such part or portion which may for any reason be declared invalid. In the event that a provision of this Management Agreement, the Shareholders Joint Venture Agreement, or any other Ancillary Agreement shall be declared to be invalid, then the Parties agree that they shall, in good faith, negotiate with one another to replace such invalid provision with a valid provision as similar as possible to that which had been held to be invalid, giving due recognition to the reason for which such provision had been held invalid.

9.10. Governmental Filings.

Fibrobeton shall be responsible for the preparation and filing of all necessary reports relating to this Management Agreement and the transactions contemplated hereby with each appropriate government agency in the Territory, and shall maintain all required governmental filings and permits current. NTI shall provide whatever information and documentation reasonably required of and available to it in connection with the preparation and filing of such reports.

9.11. Payments.

Any payment to be made to Fibrobeton pursuant to any provision of this Management Agreement shall be made by means of a wire transfer or by means of a deposit to a bona fide bank account as designated by Fibrobeton. Fibrobeton shall have the right to specify in writing any bank account to which payments due it shall be made.

9.12. Derivative Enforcement by NTI

In the event of a Material Breach or Default of this Management Agreement by Fibrobeton and/or its Agents, NTI may, derivatively for and on behalf of the Corporation, enforce the terms hereof against Fibrobeton and/or its Agents. In the event of derivative enforcement hereunder, the matter shall be adjudicated in accordance with the provisions of Article 8 hereof.

9.13. Changes Subject to Approval of NTI.

The Parties to this Management Agreement shall not change, modify or amend this Management Agreement in any respect without the prior written consent of NTI.

9.14. Changes Subject to Approval of Atagençer.

The Parties to this Management Agreement shall not change, modify or amend this Management Agreement in any respect without the prior written consent of Atagençer.

IN WITNESS WHEREOF, the Parties have executed this Management Agreement as of the day and year first above written.

FIBROBETON PRECAST CONCRETE LTD.


By	/s/



FIBRO-NTI, JOINT STOCK COMPANY


By	/s/

APPROVAL OF NORTHERN TECHNOLOGIES
INTERNATIONAL CORPORATION

By its signature hereto Northern Technologies International Corporation approves and agrees to the terms and provisions of this Management Agreement and of the form of Fibrobeton Trade Secrecy Agreement attached hereto, and agrees to be bound thereto to the extent that the terms and provisions thereof are applicable to it, it being understood that Northern Technologies International Corporation shall also have a direct right of action in its own name for the enforcement of the provisions of this Management Agreement.

NORTHERN TECHNOLOGIES INTERNATIONAL CORPORATION


By	/s/ ▇▇▇▇▇▇ ▇. ▇▇▇▇▇

APPROVAL OF ATAGENÇER, LLC

By its signature hereto ATAGENÇER, LLC approves and agrees to the terms and provisions of this Management Agreement and of the forms of Fibrobeton Trade Secrecy Agreement attached hereto, and agrees to be bound thereto to the extent that the terms and provisions thereof are applicable to it, it being understood that ATAGENÇER, LLC shall also have a direct right of action in its own name for the enforcement of the provisions of this Management Agreement.

ATAGENÇER, LLC


By	/s/ ▇▇. ▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇

MANAGEMENT AGREEMENT BY AND BETWEEN FIBRO-NTI, JOINT STOCK COMPANY AND FIBROBETON PRECAST CONCRETE LTD. DATED AS OF JUNE 24, 2001

Document Metadata

Document Metadata

Table of Contents